\u201cHaz\u0131rda insanlar \u00fcz\u0259rind\u0259 s\u0131naqdan ke\u00e7iril\u0259n 100-d\u0259n \u00e7ox peyv\u0259nd var\u201d.<\/p>\n
Bunu \u00dcmumd\u00fcnya S\u0259hiyy\u0259 T\u0259\u015fkilat\u0131n\u0131n Az\u0259rbaycan n\u00fcmay\u0259nd\u0259liyinin r\u0259hb\u0259ri Hande Harmanc\u0131 deyib.<\/p>\n
O bildirib ki, daha kliniki s\u0131na\u011fa g\u0259lm\u0259mi\u015f, laboratoriya s\u0131naqlar\u0131nda olan 180-\u0259 yax\u0131n vaksin var: \u201cBu vaksinl\u0259rd\u0259n biri d\u0259 AMEA-n\u0131n m\u00fcxbir \u00fczv\u00fc T\u0259rlan M\u0259mm\u0259dov v\u0259 onun r\u0259hb\u0259rlik etdiyi t\u0259dqiqat\u00e7\u0131lar qrupu t\u0259r\u0259find\u0259n t\u00fct\u00fcnd\u0259n haz\u0131rlanan peyv\u0259nddir. Bu peyv\u0259nd s\u0131naq m\u0259rh\u0259l\u0259sin\u0259 girib. Bu, o m\u0259naya g\u0259lir ki, klinik s\u0131naqlardan ke\u00e7\u0259rs\u0259, g\u0259l\u0259c\u0259kd\u0259 h\u0259min vaksinin istehsal\u0131 m\u00fcmk\u00fcn ola bil\u0259r. Vaksinin insanlara t\u0259tbiq olunmas\u0131 \u00fc\u00e7\u00fcn uzun zaman ke\u00e7m\u0259si laz\u0131md\u0131r. \u018fslind\u0259 bu, ill\u0259r alan m\u0259s\u0259l\u0259dir, amma COVID vaksinl\u0259rind\u0259 d\u00fcnya bunu daha tez bacard\u0131. \u0130n\u015fallah, bu da i\u015f\u0259 yarayan vaksinl\u0259rd\u0259n biri olar. N\u0259 q\u0259d\u0259r \u00e7ox vaksin olarsa, o q\u0259d\u0259r yax\u015f\u0131d\u0131r\u201d.<\/p>\n